InVivoMAb anti-mouse IL-2

Littwitz-Salomon E, Akhmetzyanova I, Vallet C, et al. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015,12:66. doi: 10.1186/s12977-015-0191-3

Bouchery T, Kyle R, Camberis M, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015,6:6970. doi: 10.1038/ncomms7970

McKinstry KK, Strutt TM, Bautista B, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014,5:5377. doi: 10.1038/ncomms6377

Marshall D, Sinclair C, Tung S, et al. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells. J Immunol. 2014,193(11):5525-33. doi: 10.4049/jimmunol.1402144

Joedicke JJ, Myers L, Carmody AB, et al. Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling. J Immunol. 2014,193(6):2952-60. doi: 10.4049/jimmunol.1400649

Mizui M, Koga T, Lieberman LA, et al. IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells. J Immunol. 2014,193(5):2168-77. doi: 10.4049/jimmunol.1400977

Myers L, Joedicke JJ, Carmody AB, et al. IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection. J Immunol. 2013,190(11):5485-95. doi: 10.4049/jimmunol.1202951

McNally A, Hill GR, Sparwasser T, et al. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A. 2011,108(18):7529-34. doi: 10.1073/pnas.1103782108

Le Saout C, Villard M, Cabasse C, et al. IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditions. PLoS One. 2010,5(9):e12659. doi: 10.1371/journal.pone.0012659

Bihl F, Pecheur J, Bréart B, et al. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol. 2010,185(4):2174-81. doi: 10.4049/jimmunol.1001486